Exclusive
June 3, 2026
GLP-1 agonists in addiction therapy – review
June 3, 2026
Safety of GLP-1 receptor agonists in body contouring surgery- a systematic review
June 3, 2026
SemaGBA- A System Dynamics Model of the Semaglutide-Responsive Gut-Brain Axis
ced pexels 14513405
June 3, 2026
Short-term effect of tirzepatide on serum calcitonin in adults with obesity
ced pexels 7723539
June 3, 2026
GLP-1 RAs and Kidney Cancer Risk- Methodological Considerations in Active-Compara
ced pexels 7904415
June 3, 2026
GLP-1 Receptor Agonists and NAION
ced pexels 8851074
June 3, 2026
GLP-1 Receptor Agonists as a Novel Solution for Antipsychotic-Induced Weight Gain
ced pexels 7857897
June 3, 2026
GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality
ced pexels 18799752
June 3, 2026
GLP-1 therapies- an emerging approach for alcohol reduction?
ced pexels 6798913
June 3, 2026
GLP‑1 Receptor Agonist Treatment and Health Outcomes in Methadone‑Treated Patien
ced pexels 19357671
June 3, 2026
GLP‑1 Receptor Agonist Use Across Preconception, Pregnancy, and the Postpartum P
ced pexels 7108344
June 3, 2026
Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Ca
ced pexels 7928141
June 3, 2026
Modes of cannabis administration, cannabis and tobacco co-use, and associations
ced pexels 29702937 1
June 3, 2026
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and
ced pexels 29702937
June 3, 2026
Repurposing semaglutide as an adjunctive treatment for cocaine use disorder- pro
ced pexels 10177660
June 3, 2026
Real-World Alcohol Use Disorder Outcomes in PatientsWith Concurrent Metabolic Dy
ced pexels 7446776
June 3, 2026
Real-World Cardiovascular Outcomes of ObesityTreatment With Tirzepatide Versus Semaglutide
In the Mix: 5 More Articles — June 03, 2026
June 3, 2026
In the Mix: 5 More Articles — June 03, 2026
What Happens If You're Stopped by Police With a Cannabis Prescription?
June 3, 2026
What Happens If You’re Stopped by Police With a Cannabis Prescription?
Researchers find older adults rarely discuss cannabis use with clinicians - Medical Xpress
June 3, 2026
Researchers find older adults rarely discuss cannabis use with clinicians – Medical Xpress
Executive order expands list of qualifying conditions for medical cannabis in Kentucky
June 3, 2026
Executive order expands list of qualifying conditions for medical cannabis in Kentucky
UK Survey Finds Majority of Medical Cannabis Patients Report Improved Mental Health Symptoms
June 3, 2026
UK Survey Finds Majority of Medical Cannabis Patients Report Improved Mental Health Symptoms
Not all hemp extracts are created equal. - YouTube
June 3, 2026
Not all hemp extracts are created equal. – YouTube
In the Mix: 6 More Articles — June 03, 2026
June 3, 2026
In the Mix: 6 More Articles — June 03, 2026
Scientist explains 'only two methods' to stop weed smoker's horrific 'scromiting' side effect
June 3, 2026
Scientist explains ‘only two methods’ to stop weed smoker’s horrific ‘scromiting’ side effect
Amendments To Keep Hemp THC Products Federally Legal Won't Get Votes ... - Marijuana Moment
June 3, 2026
Amendments To Keep Hemp THC Products Federally Legal Won’t Get Votes … – Marijuana Moment
Gov. Beshear Expands Medical Cannabis Access, Adding 15 New Qualifying Conditions
June 3, 2026
Gov. Beshear Expands Medical Cannabis Access, Adding 15 New Qualifying Conditions
Beshear clarifies list of qualified conditions for Kentucky's medical marijuana program
June 3, 2026
Beshear clarifies list of qualified conditions for Kentucky’s medical marijuana program
Cannabis companies hid health issues from consumers: Federal lawsuit - NewsNation
June 3, 2026
Cannabis companies hid health issues from consumers: Federal lawsuit – NewsNation
ced pexels 7723334
June 3, 2026
GLP-1 Drugs: New Side Effects Analysis & Evidence
ced pexels 8154267
June 3, 2026
Liraglutide vs Tirzepatide: Clinical Evidence for Weight Loss
Browse Tag

Drug Safety Profile

3 Articles
ced pexels 7722642
GLP-1 Care

GLP-1 Drugs and Muscle Loss: Clinical Evidence

CEDclinic_admin By CEDclinic_admin
Comments Off on GLP-1 Drugs and Muscle Loss: Clinical Evidence
May 11, 2026
6 Min Read

GLP-1 Clinical Relevance  #41Contextual Information  Background context; limited direct clinical applicability. ⚕ GLP-1 News  |  CED Clinic Clinical CommentaryGLP-1 Receptor AgonistWeight LossType 2 Diabetes ManagementPrimary…

ced pexels 14438368
GLP-1 Care

GLP-1 Receptor Agonist Clinical Evidence: Semaglutide

CEDclinic_admin By CEDclinic_admin
Comments Off on GLP-1 Receptor Agonist Clinical Evidence: Semaglutide
May 9, 2026
6 Min Read

GLP-1 Clinical Relevance  #48Moderate Clinical Relevance  Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News  |  CED Clinic Clinical CommentaryRegulatory AnalysisGLP-1 Receptor AgonistSemaglutideFamily…

ced pexels 7580249
GLP-1 Care

GLP-1 Cardiovascular Outcomes: Clinical Evidence & Safety

CEDclinic_admin By CEDclinic_admin
Comments Off on GLP-1 Cardiovascular Outcomes: Clinical Evidence & Safety
April 24, 2026
6 Min Read

GLP-1 Clinical Relevance  #48Moderate Clinical Relevance  Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News  |  CED Clinic CommentaryObservational StudyCardiovascular OutcomesTirzepatideCardiologyAdults with…

Copyright 2026 — CED Clinic. All rights reserved.